Jefferies has upgraded Cardinal Health (CAH) to buy from hold, citing management's emerging EPS track record. Read more here.

Cardinal Health reported an increase in revenue for two of its segments, while the departure of Optimum impacted its ...

Cardinal Health’s acquisition of Advanced Diabetes Supply Group hasn’t closed yet, but company officials said on a conference call to discuss second quarter financial results that ...

Mizuho Securities analyst Steven Valiquette has reiterated their bullish stance on CAH stock, giving a Buy rating yesterday.Invest with ...

Cardinal Health's pharmaceutical and specialty solutions segment profit increased 7% to $531 million in the second quarter.

Cardinal Health CEO Jason Hollar recounted the ... Hollar recapped Cardinal's spate of recent acquisitions that build up technology and management platforms to help administrative functions ...

Jan 30 (Reuters) - Drug distributor Cardinal Health on Thursday raised its fiscal ... made a series of strategic acquisitions to enter higher-growth healthcare sectors such as cancer care ...

Non-GAAP net earnings attributable to Cardinal Health, Inc.: net earnings attributable ... amortization and other acquisition-related costs, (6) impairments and (gain)/loss on disposal of assets ...

Management raised fiscal 2025 EPS guidance to $7.85-$8, a $0.10 increase at the midpoint, reflecting strong Pharma performance and contributions from recent acquisitions. The company expects Q3 to be ...